Biopharmaceutical
Unitedstates
Development
Combination
Therapies
M&A Advisory
Lazard
Full Credential Description
CombinatoRx. United States. Announced Date 09/11/2005. Closed Date 09/11/2005. Deal value: $48m. Initial public offering. Industry: CombinatoRx is a biopharmaceutical company focused on developing combination drug therapies.